75,000 Shares in Core Scientific, Inc. $CORZ Bought by Sculptor Capital LP

Sculptor Capital LP bought a new position in Core Scientific, Inc. (NASDAQ:CORZ) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 75,000 shares of the company’s stock, valued at approximately $1,092,000.

Several other institutional investors have also recently bought and sold shares of CORZ. AQR Capital Management LLC raised its holdings in Core Scientific by 106.1% in the 1st quarter. AQR Capital Management LLC now owns 283,432 shares of the company’s stock worth $2,052,000 after acquiring an additional 145,905 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in Core Scientific by 180.9% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,109,387 shares of the company’s stock worth $8,032,000 after acquiring an additional 714,388 shares during the period. Cetera Investment Advisers grew its position in Core Scientific by 200.0% in the 2nd quarter. Cetera Investment Advisers now owns 38,819 shares of the company’s stock worth $663,000 after purchasing an additional 25,878 shares during the last quarter. Franklin Resources Inc. acquired a new stake in Core Scientific in the 2nd quarter worth $181,000. Finally, Russell Investments Group Ltd. grew its position in Core Scientific by 61.9% in the 2nd quarter. Russell Investments Group Ltd. now owns 3,942 shares of the company’s stock worth $67,000 after purchasing an additional 1,507 shares during the last quarter.

Core Scientific Stock Performance

Shares of Core Scientific stock opened at $28.22 on Tuesday. The firm’s 50-day simple moving average is $23.01 and its 200-day simple moving average is $18.93. Core Scientific, Inc. has a twelve month low of $10.93 and a twelve month high of $30.46. The firm has a market cap of $8.97 billion, a P/E ratio of -24.75 and a beta of 5.49.

Core Scientific (NASDAQ:CORZ) last issued its earnings results on Wednesday, May 6th. The company reported ($1.06) earnings per share for the quarter, missing the consensus estimate of ($0.02) by ($1.04). The firm had revenue of $115.24 million for the quarter, compared to analyst estimates of $117.04 million. During the same quarter in the prior year, the business posted $1.25 EPS. The business’s quarterly revenue was up 44.9% compared to the same quarter last year. On average, equities analysts forecast that Core Scientific, Inc. will post 0.08 earnings per share for the current fiscal year.

Insider Buying and Selling at Core Scientific

In other news, insider Todd M. Duchene sold 10,000 shares of Core Scientific stock in a transaction dated Monday, June 8th. The shares were sold at an average price of $26.85, for a total transaction of $268,500.00. Following the sale, the insider directly owned 2,068,895 shares in the company, valued at approximately $55,549,830.75. The trade was a 0.48% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. In the last quarter, insiders have sold 70,000 shares of company stock worth $1,464,400. 1.70% of the stock is currently owned by insiders.

Analyst Ratings Changes

Several analysts have issued reports on CORZ shares. Canaccord Genuity Group set a $30.00 price target on shares of Core Scientific in a research report on Friday, May 8th. Wall Street Zen upgraded shares of Core Scientific to a “sell” rating in a research report on Saturday, March 14th. LADENBURG THALM/SH SH decreased their price target on shares of Core Scientific from $24.50 to $23.75 and set a “buy” rating on the stock in a research report on Tuesday, March 3rd. HC Wainwright restated a “buy” rating and issued a $25.00 price target on shares of Core Scientific in a research report on Tuesday, March 3rd. Finally, Sanford C. Bernstein restated an “outperform” rating and issued a $32.00 price target on shares of Core Scientific in a research report on Wednesday, June 3rd. One analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, three have issued a Hold rating and two have assigned a Sell rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $29.49.

Core Scientific Company Profile

Core Scientific, Inc (NASDAQ: CORZ) is a leading provider of large-scale blockchain infrastructure and digital asset mining services. The company develops, owns and operates high-performance data centers optimized for the mining of Bitcoin and other proof-of-work cryptocurrencies. In addition to its core mining operations, Core Scientific offers colocation, hosting and managed services designed to support institutional clients and enterprise users in deploying and scaling blockchain nodes and computing hardware.

Core Scientific’s service portfolio includes hardware procurement, deployment and maintenance, real-time monitoring, power management and network connectivity.